Schuster D

ORCID: 0000-0002-9933-8938 · 4 papers in corpus
2022
Metabolites ·doi:10.3390/metabo12020099

Naturally occurring substances are valuable resources for drug development. In this respect, chalcones are known to be antiproliferative agents against prostate cancer cell lines through various mechanisms or targets. Based on the literatur…

2018
Journal of enzyme inhibition and medicinal chemistry ·doi:10.1080/14756366.2018.1512598

There is an increasing interest in developing novel eosinophil peroxidase (EPO) inhibitors, in order to provide new treatment strategies against chronic inflammatory and neurodegenerative diseases caused by eosinophilic disorder. Within thi…

2017
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2017.03.008

Several members of the short-chain dehydrogenase/reductase (SDR) enzyme family play fundamental roles in adrenal and gonadal steroidogenesis as well as in the metabolism of steroids, oxysterols, bile acids, and retinoids in peripheral tissu…

2015
Molecules (Basel, Switzerland) ·doi:10.3390/molecules201219880

Computational methods are well-established tools in the drug discovery process and can be employed for a variety of tasks. Common applications include lead identification and scaffold hopping, as well as lead optimization by structure-activ…